Antiresorptive drugs (ARDs), such as bisphosphonates or denosumab, that prevent bone resorption are widely used in patients with osteoporosis or with cancer that has metastasized to the bones. Although osteonecrosis of the jaw (ONJ) is a well-documented complication of ARD use, the benefits ARDs outweigh the complication. Thus, research has focused on finding ways to prevent or reduce the risk of developing ONJ. Dentists, as part of a multi-professional team, have a critical role in preventing ONJ. However, many dentists tend to hesitate to provide dental care to patients with ONJ, or tend to think that it is a problem to be dealt with by oral surgeons. This review gives an overview of ARD-related ONJ and provides the guidelines for dental care in patients taking ARDs to lower the risk of developing ONJ.

Citations

Citations to this article as recorded by  

• Assessment of the occurrence of apical periodontitis and endodontically treated/non-treated teeth in a Lower Austrian patient population treated for osteoporosis: a cohort study
  Pascal Grün, Marius Meier, Johannes Dittrich, Arb Gjergjindreaj, Dragan Ströbele, Florian Pfaffeneder-Mantai, Sepideh Hatamikia, Margrit-Ann Geibel, Dritan Turhani
  Annals of Medicine & Surgery.2024; 86(9): 5049.     CrossRef
• Endodontic and periapical status of patients with osteoporosis
  Selin Goker Kamalı, Dilek Turkaydın
  The Journal of the American Dental Association.2024; 155(12): 1022.     CrossRef
• Postoperative pain in oncological patients subjected to nonsurgical root canal treatment: a prospective case-control study
  Kaline Romeiro, Luciana F. Gominho, Isabela N. Rôças, José F. Siqueira Jr
  Clinical Oral Investigations.2024;[Epub]     CrossRef
• Periodontal ligament‐associated protein‐1 promotes osteoclastogenesis in mice by modulating TGF‐β1/Smad1 pathway
  Shuang Liu, Xijiao Yu, Qiushuang Guo, Shuaiqi Zhao, Kaixian Yan, Meng Hou, Fuxiang Bai, Shu Li
  Journal of Periodontology.2024; 95(2): 146.     CrossRef
• What Is the Appropriate Antibiotic Administration During Tooth Extractions in Patients Receiving High-Dose Denosumab?
  Eiji Iwata, Takumi Hasegawa, Hiroaki Ohori, Toshiya Oko, Tsutomu Minamikawa, Daisuke Miyai, Masaki Kobayashi, Naoki Takata, Shungo Furudoi, Junichiro Takeuchi, Kosuke Matsumoto, Akira Tachibana, Masaya Akashi
  Cureus.2024;[Epub]     CrossRef
• Perfil Odontológico dos Pacientes em Uso de Bisfosfonatos em um Hospital Oncológico
  Jade Fontenele Tagliabue, Lísia Daltro Borges Alves, Héliton Spíndola Antunes
  Revista Brasileira de Cancerologia.2024;[Epub]     CrossRef
• Analysis of the Degree of Information of Dental Surgeons about Antiresorptive Drugs According to the Time Since Graduation in Dentistry
  Flávia Godinho Costa Wanderley Rocha, Roberto Paulo Correia de Araújo
  Pesquisa Brasileira em Odontopediatria e Clínica Integrada.2023;[Epub]     CrossRef
• Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS
  Athanasios D Anastasilakis, Jessica Pepe, Nicola Napoli, Andrea Palermo, Christos Magopoulos, Aliya A Khan, M Carola Zillikens, Jean-Jacques Body
  The Journal of Clinical Endocrinology & Metabolism.2022; 107(5): 1441.     CrossRef
• Accuracy of Dynamic Navigation for Non-Surgical Endodontic Treatment: A Systematic Review
  Egle Marija Jonaityte, Goda Bilvinaite, Saulius Drukteinis, Andres Torres
  Journal of Clinical Medicine.2022; 11(12): 3441.     CrossRef
• Periapical status in patients affected by osteoporosis: A retrospective clinical study
  Erika Cadoni, Francesca Ideo, Giuseppe Marongiu, Silvia Mezzena, Luca Frigau, Quirico Mela, Antonio Capone, Henry F. Duncan, Elisabetta Cotti
  Clinical and Experimental Dental Research.2022; 8(5): 1068.     CrossRef
• LONG-TERM USE OF DENOSUMAB IN GIANT CELL TUMORS AND VERTEBRAL ANEURYSMAL BONE CYSTS
  Pedro Luis Bazán, Micaela Cinalli, Felipe Lanari Zabiaur, Roberto Castelli, Claudio Silveri, José Luis Monayer, Enrique Gustavo Gobbi, Alejandro Maria Steverlynck
  Coluna/Columna.2022;[Epub]     CrossRef
• A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients
  Seoyeon Jung, Jaeyeon Kim, Jin Hoo Park, Ki-Yeol Kim, Hyung Jun Kim, Wonse Park
  Scientific Reports.2022;[Epub]     CrossRef
• Management of Patients under Treatment with Monoclonal Antibodies and New Biological Therapies
  Marta Amigo-Basilio, Covadonga Álvarez-González, Carlos Cobo-Vázquez, Isabel Leco-Berrocal, Luis Miguel Sáez-Alcaide, Cristina Méniz-García
  Applied Sciences.2021; 11(11): 4865.     CrossRef
• Medication-Related Osteonecrosis of the Jaw, a Hidden Enemy. An Integrative Review
  Odel Chediak-Barbur
  Universitas Odontologica.2021;[Epub]     CrossRef
• A Retrospective Observational Study of Risk Factors for Denosumab-Related Osteonecrosis of the Jaw in Patients with Bone Metastases from Solid Cancers
  Satoe Okuma, Yuhei Matsuda, Yoshiki Nariai, Masaaki Karino, Ritsuro Suzuki, Takahiro Kanno
  Cancers.2020; 12(5): 1209.     CrossRef